Rise Advisors’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-310
Closed -$22.7K 473
2025
Q3
$22.7K Hold
310
0.01% 510
2025
Q2
$19K Buy
310
+9
+3% +$502 0.01% 569
2025
Q1
$17.5K Sell
301
-155
-34% -$9.79K 0.01% 588
2024
Q4
$24.3K Sell
456
-50
-10% -$2.45K 0.01% 525
2024
Q3
$22K Hold
506
0.01% 630
2024
Q2
$14.2K Hold
506
0.01% 863
2024
Q1
$13.6K Buy
506
+456
+912% +$13K 0.01% 919
2023
Q4
$1.4K Hold
50
﹤0.01% 491
2023
Q3
$1.06K Hold
50
﹤0.01% 527
2023
Q2
$1.7K Sell
50
-50
-50% -$1.67K ﹤0.01% 535
2023
Q1
$3.24K Hold
100
﹤0.01% 510
2022
Q4
$3.36K Hold
100
﹤0.01% 498
2022
Q3
$3K Hold
100
﹤0.01% 492
2022
Q2
$3K Buy
100
+50
+100% +$1.97K ﹤0.01% 498
2022
Q1
$3K Hold
50
﹤0.01% 478
2021
Q4
$2.51K Buy
+50
New +$3.25K ﹤0.01% 504

Other funds holding DOCS

Rise Advisors's DOCS Position: Q4 2025 in Review

Rise Advisors sold out of Doximity (DOCS) in Q4 2025, closing a stake of 310 shares — an estimated $22.7K sold.

Rise Advisors first reported a position in DOCS in Q4 2021 and held it in 16 quarters. The position peaked at $24.3K in Q4 2024. 470 funds tracked by Wall St. Rank hold DOCS as of Q4 2025.

  • Rise Advisors reported no remaining Doximity position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 310 Doximity shares in Q4 2025, an estimated $22.7K.
  • Rise Advisors first reported a position in Doximity in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Doximity position peaked at $24.3K in Q4 2024.
  • 470 funds tracked by Wall St. Rank held Doximity as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.